PLUS THERAPEUTICS, INC. PSTV
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
-107.82
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $5.2M | -$22.4M | — | -$20.8M | $4.0M |
| 2024 | $5.8M | -$13.0M | — | -$10.7M | -$8.9M |
| 2023 | $4.9M | -$13.3M | — | -$13.0M | -$1.3M |
| 2022 | — | -$20.3M | — | — | $6.4M |
| 2021 | — | -$13.4M | — | — | $10.8M |
| 2020 | — | -$8.2M | — | — | $3.0M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | 2026-04-01 | Option exercise | 38,323 | — |
| Sims Andrew John Hugh MacIntyre | Chief Financial Officer | 2026-04-01 | Option exercise | 29,129 | — |
| HEDRICK MARC H | Chief Executive Officer | 2026-04-01 | Option exercise | 159,681 | — |
| HEDRICK MARC H | Chief Executive Officer | 2026-04-01 | Option exercise | 201,632 | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -107.82 (distress)
- Working capital / assets 0.175
- Retained earnings / assets -31.6
- EBIT / assets -0.937
- Equity / liabilities 0.324
Source: SEC EDGAR filings · CIK 0001095981 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.